https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Int J Hyperthermia 2007 Dec;23(8):623-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Int J Hyperthermia 2007 Dec;23(8):623-432007-12-01 00:00:002019-02-15 08:35:22RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Int. J. Oncol. 2007 Dec;31(6):1357-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Int. J. Oncol. 2007 Dec;31(6):1357-652007-12-01 00:00:002007-12-01 00:00:00Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-52007-12-01 00:00:002007-12-01 00:00:00Experimental evidence for the efficacy of combined therapy of CPT-11 and hyperthermia for squamous cell carcinoma of the esophagus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-26 / Eur. Urol. 2008 Apr;53(4):694-708
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-26 / Eur. Urol. 2008 Apr;53(4):694-7082007-11-26 00:00:002019-02-15 09:24:03Advances in specific immunotherapy for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-09 / Blood 2008 Feb;111(3):1504-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-09 / Blood 2008 Feb;111(3):1504-112007-11-09 00:00:002019-02-15 09:25:30Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-08 / J. Invest. Dermatol. 2008 Apr;128(4):949-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-08 / J. Invest. Dermatol. 2008 Apr;128(4):949-562007-11-08 00:00:002007-11-08 00:00:00Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-72007-11-01 00:00:002019-02-15 08:46:53[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Int. J. Oncol. 2007 Nov;31(5):1009-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Int. J. Oncol. 2007 Nov;31(5):1009-192007-11-01 00:00:002020-06-23 09:32:35Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Br. J. Haematol. 2007 Nov;139(3):415-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Br. J. Haematol. 2007 Nov;139(3):415-242007-11-01 00:00:002019-02-15 08:51:00Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-92007-11-01 00:00:002019-02-15 08:38:09[The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo]
